Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100

Toll-like receptor (TLR) 3 agonists emerged as attractive candidates for vaccination strategies against tumors and pathogens. An important mechanism of action of such agonists is based on the activation of TLR3-expressing dendritic cells (DCs), which display a unique capacity to induce and stimulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Naumann, Kai, Wehner, Rebekka, Schwarze, Anett, Petzold, Christiane, Schmitz, Marc, Rohayem, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878805/
https://www.ncbi.nlm.nih.gov/pubmed/24454470
http://dx.doi.org/10.1155/2013/283649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878805/
https://www.ncbi.nlm.nih.gov/pubmed/24454470
http://dx.doi.org/10.1155/2013/283649

Ejemplares similares